Next Article in Journal
Structure–Activity Relationship Studies Using Natural and Synthetic Okadaic Acid/Dinophysistoxin Toxins
Next Article in Special Issue
Anti-Melanogenic Activity of Gagunin D, a Highly Oxygenated Diterpenoid from the Marine Sponge Phorbas sp., via Modulating Tyrosinase Expression and Degradation
Previous Article in Journal
Biscogniauxone, a New Isopyrrolonaphthoquinone Compound from the Fungus Biscogniauxia mediterranea Isolated from Deep-Sea Sediments
Previous Article in Special Issue
Novel Conopeptides of Largely Unexplored Indo Pacific Conus sp.
Article Menu

Export Article

Open AccessReview
Mar. Drugs 2016, 14(11), 205; doi:10.3390/md14110205

Ceramide as a Target of Marine Triterpene Glycosides for Treatment of Human Myeloid Leukemia

1
Department of Biochemistry, Dong-A University College of Medicine, 32 Daesingongwon-ro, Seo-Gu, Busan 49201, Korea
2
G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Science, Vladivostok 690022, Russia
3
Department of Bioorganic Chemistry and Biotechnology, School of Natural Sciences, Far East Federal University, Vladivostok 690091, Russia
*
Author to whom correspondence should be addressed.
Academic Editor: Kirsten Benkendorff
Received: 13 September 2016 / Revised: 19 October 2016 / Accepted: 28 October 2016 / Published: 3 November 2016
(This article belongs to the Collection Bioactive Compounds from Marine Invertebrates)
View Full-Text   |   Download PDF [1207 KB, uploaded 3 November 2016]   |  

Abstract

Acute myeloid leukemia (AML) is a heterogeneous myeloid clonal disorder exhibiting the accumulation of immature myeloid progenitors in the bone marrow and peripheral blood. Standard AML therapy requires intensive combination chemotherapy, which leads to significant treatment-related toxicity. The search for new, low toxic marine agents, inducing the generation of ceramide in leukemic cells is a new approach to improve the therapy of leukemia. This review focuses on the metabolism of sphingolipids, the role of ceramide in treating leukemia, and the antitumor activity, related to ceramide metabolism, of some marine metabolites, particularly stichoposides, triterpene glycosides extracted from sea cucumbers of the family Stichopodiidae. View Full-Text
Keywords: stichoposides; anti-leukemic activity; ceramide; sphingomyelinase; ceramide synthase stichoposides; anti-leukemic activity; ceramide; sphingomyelinase; ceramide synthase
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Yun, S.-H.; Shin, S.-W.; Stonik, V.A.; Park, J.-I. Ceramide as a Target of Marine Triterpene Glycosides for Treatment of Human Myeloid Leukemia. Mar. Drugs 2016, 14, 205.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top